CN108314687A - 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)The synthesis of -one derivative - Google Patents

1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)The synthesis of -one derivative Download PDF

Info

Publication number
CN108314687A
CN108314687A CN201711440250.7A CN201711440250A CN108314687A CN 108314687 A CN108314687 A CN 108314687A CN 201711440250 A CN201711440250 A CN 201711440250A CN 108314687 A CN108314687 A CN 108314687A
Authority
CN
China
Prior art keywords
imidazo
dihydrobenzos
pyrazine
derivative
milliliters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711440250.7A
Other languages
Chinese (zh)
Inventor
徐志刚
陈中祝
唐典勇
孟江平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing University of Arts and Sciences
Original Assignee
Chongqing University of Arts and Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing University of Arts and Sciences filed Critical Chongqing University of Arts and Sciences
Priority to CN201711440250.7A priority Critical patent/CN108314687A/en
Publication of CN108314687A publication Critical patent/CN108314687A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a kind of 1,2 dihydrobenzos [4,5] imidazo [1,2 a] pyrazines 3(4H)The preparation method of ketone derivatives is deprotected in acid condition first based on the present invention is using Ugi reactions, using microwave radiation technology cyclization, obtained benzimidazole product.By simply post-processing, then under alkaline condition, obtain 1,2 dihydrobenzo [4,5] imidazo [1, the 2 a] pyrazines 3 with potential antitumor activity(4H)The features such as ketone derivatives, this method are easy to get compared with conventional method with raw material, and synthesis technology is brief, and post-processing is simple, and yield is higher.

Description

1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)-one derivative Synthesis
Technical field
The invention belongs to noval chemical compound preparation method fields, especially one kind 1,2- dihydrobenzos [4,5] imidazo [1,2- A] pyrazine -3(4H)The synthetic method of -one derivative and its application.
Background technology
Simultaneously pyrazinones derivative generally has preferable bioactivity to benzimidazole, has antitumor and antibacterial activity. Early-stage study result is shown:Substituted polyaromatic and heteroaryl pyrazino ketone compound object, can be with the serine of inhibition of coagulation cascade Protease can inhibit the obstruction disease in relation to blood and blood vessel such as formation, fibrinous generation, thrombus of platelet aggregation object The grumeleuse in blood vessel can also be prevented or be treated to disease, therapeutically can be used to treat or prevent unstable angina, cardiac muscle stalk The blood vascular diseases such as plug, atrial fibrillation, Deep vain thrombosis.The synthesis of the compound mainly uses traditional conjunction At method, synthesis step is longer, complex process.Chemists are attempting always different synthetic methods in recent years, wherein utilizing Multi-component reaction has obtained good utilization in the synthesis of such chemical combination.It has been reported that(Synlett, 2014, 25, 225- 228), boc-protected amino acid can be used as the raw material of multi-component reaction, be then condensed in acid condition with ester group To such compound.Also have been reported that be use boc-protected isocyanide as raw material(Tetrahedron Letters, 2015, 56, 4616-4618), synthesizing benzimidazole ring first, then cyclization obtains such compound again.The present invention is to utilize price just The bromoacetic acid being preferably easy to get is raw material, by with benzimidazole cyclic condensation, obtain benzimidazole and pyrazinones derivative.The method It is compared with other methods, shows as raw material and be easy to get, the features such as synthesis technology is brief, and post-processing is simple, and yield is higher.
Invention content
The purpose of the present invention is to provide 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazines -3(4H)-one derivative Preparation method and applications, the present invention have post-processing operation is simple, reaction condition is mild, synthetic route is short, yield is higher, The advantages that at low cost.
What the purpose of the present invention was achieved through the following technical solutions:
It is an object of the invention to overcome existing synthetic route, provide a kind of new 1,2- dihydrobenzos [4,5] imidazo [1, 2-a] pyrazine -3(4H)The synthetic method of -one derivative.
1. a kind of 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)The general structure of -one derivative is such as Under:
2. 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 wherein described in 1(4H)-one derivative, institute The R stated1For hydrogen atom, methyl and halogen;R2For carbon number be 1-6 alkyl, phenyl substituent;R3For carbon number be 1-6 alkyl, Aryl and heteroaryl.
3. a kind of 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)The preparation method of -one derivative, It is characterized in that:Using multicomponent Ugi compounds obtained by the reaction under the premise of need not purify, using 10% trifluoroacetic acid and The acid leach solution of dichloroethanes, microwave-assisted reaction are reacted 10 minutes under conditions of 60 DEG C, so that it may to obtain de- Boc The benzimidazoles compound of protection.Then the compound is under the alkaline condition of potassium carbonate, again by microwave-assisted reaction, It is reacted 10 minutes under conditions of 80 DEG C, obtains target product, this reaction process is short, and post-reaction treatment is simple.
4. moreover, synthetic route is as follows:
1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 described in 5.(4H)-one derivative is preparing anti-swell Application in tumor medicine.
The advantages and positive effects of the present invention.
(1)The present invention first passes around based on Ugi reacts and sloughs blocking group formation benzimidazole under acid condition Compound, then again under alkaline condition shut pyrazinones ring, by simple step purification operations, obtain that there is potential life Active 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 of object(4H)-one analog derivative.
(2)The present invention has that synthesis step is brief, a step purification operations, and reaction condition is mild, easy post-processing, yield compared with The advantages that high, at low cost.
Description of the drawings
Fig. 1 is 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)The general structure of -one derivative.
Fig. 2 is 2- benzyls -4- of the present invention(3- bromophenyls)- 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 (4H)The nuclear magnetic spectrogram of -one.
Fig. 3 is 2- benzyls -4- of the present invention(4- methoxyphenyls)- 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrrole Piperazine -3(4H)The nuclear magnetic spectrogram of -one.
Fig. 4 is 2- benzyls -4- phenyl -1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 of the present invention(4H)-one Nuclear magnetic spectrogram.
Fig. 5 is 2- benzyls -4- of the present invention(P-methylphenyl)- 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 (4H)The nuclear magnetic spectrogram of -one.
Fig. 6 is 2- benzyls -4- of the present invention(3,4- dichlorophenyls)- 7,8- dimethyl -1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)The nuclear magnetic spectrogram of -one.
Fig. 7 is 2- benzyls -4- of the present invention(4- chlorphenyls)- 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 (4H)The nuclear magnetic spectrogram of -one.
Fig. 8 is 2- cyclohexyl -4- phenyl -1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 of the present invention(4H)- The nuclear magnetic spectrogram of ketone.
Fig. 9 is 4- of the present invention(3,4- dichlorophenyls)- 2- phenethyl -1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrrole Piperazine -3(4H)The nuclear magnetic spectrogram of -one.
Specific implementation mode
In order to understand the present invention, with reference to embodiment, the invention will be further described that following embodiments are illustrative , it is not restrictive, protection scope of the present invention cannot be limited with following embodiments.
The present invention provides following formula: compound:
1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 wherein described in 1(4H)-one derivative, described in R1For hydrogen atom, methyl and halogen;R2For carbon number be 1-6 alkyl, phenyl substituent;R3For carbon number be 1-6 alkyl, aryl And heteroaryl.
The present invention is special, and compound includes:(1)2- benzyls -4-(3- bromophenyls)- 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)-one.
(2)2- benzyls -4-(4- methoxyphenyls)- 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)- Ketone.
(3)2- benzyls -4- phenyl -1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)-one.
(4)2- benzyls -4-(P-methylphenyl)- 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)-one.
(5)2- benzyls -4-(3,4- dichlorophenyls)- 7,8- dimethyl -1,2- dihydrobenzos [4,5] imidazo [1,2-a] Pyrazine -3(4H)-one.
(6)2- benzyls -4-(4- chlorphenyls)- 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)-one.
(7)2- cyclohexyl -4- phenyl -1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)-one.
(8)4-(3,4- dichlorophenyls)- 2- phenethyl -1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 (4H)-one.
1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 of synthesis wherein described in 1(4H)The pass of -one derivative Key step is:Reacted using multicomponent Ugi, obtain Ugi products under normal temperature condition, the compound under conditions of unpurified, into Row reacts in next step, using under the acid condition of 10% trifluoroacetic acid and dichloroethanes, is reacted at 60 DEG C again by microwave radiation technology 10 minutes, obtain benzimidazoles derivative.Then, using the alkaline condition of potassium carbonate, microwave-assisted reaction, in 80 DEG C of item It is reacted 10 minutes under part, then passes through a step purification operations, so that it may to obtain 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrrole Piperazine -3(4H)The features such as -one analog derivative, this reaction process is brief, and post-reaction treatment is simple, and yield is higher.
What the separating-purifying of the present invention was all made of is the method for column chromatography, and solvent used is ethyl acetate and n-hexane Mixture.
1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)The synthetic route of -one derivative,
Building-up process is illustrated below by examples of implementation.
Embodiment 1
Wherein R1For hydrogen atom, R2For phenyl, R3For heteroaryl, i.e. 2- benzyls -4-(3- bromophenyls)- 1,2- dihydrobenzos [4,5] Imidazo [1,2-a] pyrazine -3(4H)The synthesis of -one, is as follows:
In the micro-wave oven reaction tube of 10 milliliters of sizes, first by boc-protected aniline compound(0.5 mM)With 3- bromobenzenes Formaldehyde(0.5 mM)It is dissolved in 1.0 milliliters of methanol, then again by bromoacetic acid(0.5 mM)With benzyl isocyanide chemical combination Object(0.5 mM)It sequentially adds in the solution, is stirred a whole night under reaction solution room temperature, then use thin-layer chromatography to detect anti- It answers, solution is dried up using nitrogen.Then after using the dissolving of the solvent of 10% trifluoroacetic acid and dichloroethanes, in 60 DEG C of conditions of microwave Under react again 10 minutes, after solution is spin-dried for use dichloromethane(30 milliliters)Dissolving, the sodium bicarbonate solution washing of saturation (2 × 15 milliliters), obtained organic phase product are dissolved with 5.0 milliliters of acetonitrile again, add potassium carbonate(2.5 mM), It is reacted 10 minutes for 80 DEG C in micro-wave oven.The solution uses dichloromethane after being spin-dried for(30 milliliters)Dissolving, then uses saturated salt solution It washs (2 × 15 milliliters).After organic phase is using magnesium sulfate drying, silicagel column is detached obtained product again, obtains target 2- benzyls -4-(3- bromophenyls)- 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)-one compound, yield 81%。
1H NMR (400 MHz, CDCl3) δ7.75 (d, J = 8.1 Hz, 1H), 7.48 (d, J = 7.9 Hz, 1H), 7.41 (s, 1H), 7.32-7.17 (m, 8H), 7.08-7.03 (m, 2H), 6.05 (s, 1H), 4.88-4.84 (m, 1H), 4.81-4.71 (m, 2H), 4.68-4.62 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 164.0, 144.6, 143.7, 137.5, 134.9, 132.9, 132.3, 130.7, 129.6, 129.1, 128.3, 124.9, 123.4, 123.4, 123.3, 119.9, 110.0, 60.2, 50.8, 44.6. LC/ MS calculated for C23H19BrN3O [M+H]+, 432; found 432。
Embodiment 2
Wherein R1For hydrogen atom, R2For phenyl, R3For benzyl, i.e. 2- benzyls -4-(4- methoxyphenyls)- 1,2- dihydrobenzos [4, 5] imidazo [1,2-a] pyrazine -3(4H)The synthesis of -one, is as follows:
In the micro-wave oven reaction tube of 10 milliliters of sizes, first by boc-protected aniline compound(0.5 mM)With 4- methoxies Benzaldehyde(0.5 mM)It is dissolved in 1.0 milliliters of methanol, then again by bromoacetic acid(0.5 mM)With benzyl isocyanide Compound(0.5 mM)It sequentially adds in the solution, stirs a whole night under reaction solution room temperature, then examined using thin-layer chromatography Reaction is surveyed, solution is dried up using nitrogen.Then after the solvent dissolving for using 10% trifluoroacetic acid and dichloroethanes, in 60 DEG C of microwave Under the conditions of react again 10 minutes, after solution is spin-dried for use dichloromethane(30 milliliters)Dissolving, the sodium bicarbonate solution of saturation It washs (2 × 15 milliliters), obtained organic phase product is dissolved with 5.0 milliliters of acetonitrile again, adds potassium carbonate(2.5 mmoles You), reacted 10 minutes for 80 DEG C in micro-wave oven.The solution uses dichloromethane after being spin-dried for(30 milliliters)Dissolving, then with saturation Brine It (2 × 15 milliliters).After organic phase is using magnesium sulfate drying, silicagel column is detached obtained product again, is obtained To target 2- benzyls -4-(4- methoxyphenyls)- 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)-one, production Rate 76%.
1H NMR (400 MHz, CDCl3) δ 7.74 (d, J = 8.1 Hz, 1H), 7.34-7.28 (m, 4H), 7.25-7.22 (m, 2H), 7.18 (t, J = 7.6 Hz, 1H), 7.11-7.08 (m, 3H), 6.85 (d, J = 8.7 Hz, 2H), 6.06 (s, 1H), 4.86 (d, J = 14.6 Hz, 1H), 4.80-4.71 (m, 2H), 4.66 (d, J = 14.6 Hz, 1H), 3.78 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 164.9, 160.1, 144.9, 143.7, 135.1, 133.0, 129.0, 128.3, 128.2, 127.5, 127.3, 123.2, 123.0, 119.7, 114.6, 110.2, 60.4, 55.3, 50.6, 44.6. LC/MS calculated for C24H22N3O2 [M +H]+, 384; found 384。
Embodiment 3
Wherein R1For hydrogen atom, R2For phenyl, R3For alkyl, i.e. 2- benzyls -4- phenyl -1,2- dihydrobenzo [4,5] imidazo [1,2-a] pyrazine -3(4H)The synthesis of -one, is as follows:
In the micro-wave oven reaction tube of 10 milliliters of sizes, first by boc-protected aniline compound(0.5 mM)And benzaldehyde (0.5 mM)It is dissolved in 1.0 milliliters of methanol, then again by bromoacetic acid(0.5 mM)With benzyl isocyanide compound (0.5 mM)It sequentially adds in the solution, is stirred a whole night under reaction solution room temperature, then use thin-layer chromatography detection reaction, Solution is dried up using nitrogen.Then after the solvent dissolving for using 10% trifluoroacetic acid and dichloroethanes, under the conditions of 60 DEG C of microwave again Secondary response 10 minutes uses dichloromethane after being spin-dried for solution(30 milliliters)Dissolving, saturation sodium bicarbonate solution washing (2 × 15 milliliters), obtained organic phase product is dissolved with 5.0 milliliters of acetonitrile again, adds potassium carbonate(2.5 mM), in microwave It is reacted 10 minutes for 80 DEG C in stove.The solution uses dichloromethane after being spin-dried for(30 milliliters)Then saturated common salt water washing is used in dissolving (2 × 15 milliliters).After organic phase is using magnesium sulfate drying, silicagel column is detached obtained product again, obtains target 2- benzyls Base -4- phenyl -1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)-one compound, yield 72%.
1H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 8.1 Hz, 1H), 7.35-7.29 (m, 7H), 7.23-7.15 (m, 5H), 7.10 (d, J = 8.1 Hz, 1H), 6.12 (s, 1H), 4.87 (d, J = 14.6 Hz, 1H), 4.80-4.71 (m, 2H), 4.64 (d, J = 14.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 164.7, 144.9, 143.7, 135.2, 135.1, 133.0, 129.2, 129.0, 128.3, 128.2, 126.3, 123.2, 123.1, 119.7, 110.1, 60.9, 50.7, 44.6. LC/MS calculated for C23H20N3O [M+H]+, 354; found 354。
Embodiment 4
Wherein R1For hydrogen atom, R2For phenyl, R3For benzyl, i.e. 2- benzyls -4-(P-methylphenyl)- 1,2- dihydrobenzos [4,5] miaow Azoles simultaneously [1,2-a] pyrazine -3(4H)The synthesis of -one, is as follows:
In the micro-wave oven reaction tube of 10 milliliters of sizes, first by boc-protected aniline compound(0.5 mM)With to methyl Benzaldehyde(0.5 mM)It is dissolved in 1.0 milliliters of methanol, then again by bromoacetic acid(0.5 mM)With benzyl isocyanide Close object(0.5 mM)It sequentially adds in the solution, stirs a whole night under reaction solution room temperature, then detected using thin-layer chromatography Reaction, solution are dried up using nitrogen.Then after using the dissolving of the solvent of 10% trifluoroacetic acid and dichloroethanes, in 60 DEG C of items of microwave It is reacted again under part 10 minutes, dichloromethane is used after solution is spin-dried for(30 milliliters)Dissolving, the sodium bicarbonate solution of saturation are washed It washs (2 × 15 milliliters), obtained organic phase product is dissolved with 5.0 milliliters of acetonitrile again, adds potassium carbonate(2.5 mM), It is reacted 10 minutes for 80 DEG C in micro-wave oven.The solution uses dichloromethane after being spin-dried for(30 milliliters)Dissolving, then uses saturated common salt Water washing (2 × 15 milliliters).After organic phase is using magnesium sulfate drying, silicagel column is detached obtained product again, obtains mesh Mark 2- benzyls -4-(P-methylphenyl)- 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)-one compound, yield 84%。
1H NMR (400 MHz, CDCl3) δ 7.74 (d, J = 8.1 Hz, 1H), 7.34-7.28 (m, 4H), 7.24-7.22 (m, 2H), 7.20-7.04 (m, 6H), 6.07 (s, 1H), 4.87 (d, J = 14.6 Hz, 1H), 4.80-4.70 (m, 2H), 4.63 (d, J = 14.6 Hz, 1H), 2.32 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 164.8, 144.9, 143.7, 139.0, 135.1, 133.1, 132.3, 129.9, 129.0, 128.3, 128.2, 126.2, 123.2, 123.0, 119.7, 110.1, 60.7, 50.6, 44.6, 21.1. LC/ MS calculated for C24H22N3O [M+H]+, 368; found 368。
Embodiment 5
Wherein R1For methyl, R2For phenyl, R3For benzyl, i.e. 2- benzyls -4-(3,4- dichlorophenyls)- 7,8- dimethyl -1,2- two Hydrogen benzo [4,5] imidazo [1,2-a] pyrazine -3(4H)The synthesis of -one, is as follows:
In the micro-wave oven reaction tube of 10 milliliters of sizes, first by boc-protected aniline compound(0.5 mM)With 3,4- bis- Chlorobenzaldehyde(0.5 mM)It is dissolved in 1.0 milliliters of methanol, then again by bromoacetic acid(0.5 mM)With benzyl isocyanide Compound(0.5 mM)It sequentially adds in the solution, stirs a whole night under reaction solution room temperature, then examined using thin-layer chromatography Reaction is surveyed, solution is dried up using nitrogen.Then after the solvent dissolving for using 10% trifluoroacetic acid and dichloroethanes, in 60 DEG C of microwave Under the conditions of react again 10 minutes, after solution is spin-dried for use dichloromethane(30 milliliters)Dissolving, the sodium bicarbonate solution of saturation It washs (2 × 15 milliliters), obtained organic phase product is dissolved with 5.0 milliliters of acetonitrile again, adds potassium carbonate(2.5 mmoles You), reacted 10 minutes for 80 DEG C in micro-wave oven.The solution uses dichloromethane after being spin-dried for(30 milliliters)Dissolving, then with saturation Brine It (2 × 15 milliliters).After organic phase is using magnesium sulfate drying, silicagel column is detached obtained product again, is obtained To target 2- benzyls -4-(3,4- dichlorophenyls)- 7,8- dimethyl -1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 (4H)-one compound, yield 79%.
1H NMR (400 MHz, CDCl3) δ 7.50 (s, 1H), 7.39 (d, J = 8.3 Hz, 1H), 7.33-7.30 (m, 4H), 7.23-7.21 (m, 2H), 6.94 (dd, J = 8.4, 2.1 Hz, 1H), 6.80 (s, 1H), 5.98 (s, 1H), 4.84 (d, J = 14.6 Hz, 1H), 4.70 (s, 2H), 4.61 (d, J = 14.6 Hz, 1H), 2.34 (s, 3H), 2.28 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 163.8, 143.5, 142.2, 135.5, 134.9, 133.6, 133.4, 132.7, 132.6, 131.2, 131.1, 129.1, 128.4, 128.4, 128.3, 125.5, 119.9, 109.9, 59.7, 50.8, 44.6, 20.5, 20.3. LC/MS calculated for C25H22Cl2N3O [M+H]+, 450; found 450。
Embodiment 6
Wherein R1For hydrogen atom, R2For phenyl, R3For benzyl, i.e. 2- benzyls -4-(4- chlorphenyls)- 1,2- dihydrobenzos [4,5] miaow Azoles simultaneously [1,2-a] pyrazine -3(4H)The synthesis of -one, is as follows:
In the micro-wave oven reaction tube of 10 milliliters of sizes, first by boc-protected aniline compound(0.5 mM)With 4- chlorobenzenes Formaldehyde(0.5 mM)It is dissolved in 1.0 milliliters of methanol, then again by bromoacetic acid(0.5 mM)With benzyl isocyanide chemical combination Object(0.5 mM)It sequentially adds in the solution, is stirred a whole night under reaction solution room temperature, then use thin-layer chromatography to detect anti- It answers, solution is dried up using nitrogen.Then after using the dissolving of the solvent of 10% trifluoroacetic acid and dichloroethanes, in 60 DEG C of conditions of microwave Under react again 10 minutes, after solution is spin-dried for use dichloromethane(30 milliliters)Dissolving, the sodium bicarbonate solution washing of saturation (2 × 15 milliliters), obtained organic phase product are dissolved with 5.0 milliliters of acetonitrile again, add potassium carbonate(2.5 mM), It is reacted 10 minutes for 80 DEG C in micro-wave oven.The solution uses dichloromethane after being spin-dried for(30 milliliters)Dissolving, then uses saturated salt solution It washs (2 × 15 milliliters).After organic phase is using magnesium sulfate drying, silicagel column is detached obtained product again, obtains target 2- benzyls -4-(4- chlorphenyls)- 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)-one compound, yield 83%。
1H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 8.1 Hz, 1H), 7.32-7.28 (m, 6H), 7.24-7.17 (m, 3H), 7.10 (d, J = 8.5 Hz, 2H), 7.05 (d, J = 8.1 Hz, 1H), 6.08 (s, 1H), 4.85 (d, J = 14.6 Hz, 1H), 4.75 (s, 2H), 4.65 (d, J = 14.6 Hz, 1H);13C NMR (100 MHz, CDCl3) δ 164.2, 144.7, 143.7, 135.2, 134.9, 133.7, 132.9, 129.5, 129.1, 128.3, 127.7, 123.4, 123.2, 119.8, 110.0, 60.2, 50.7, 44.6. LC/ MS calculated for C23H19ClN3O [M+H]+, 388; found 388。
Embodiment 7
Wherein R1For hydrogen atom, R2For phenyl, R3For alkyl, i.e. 2- cyclohexyl -4- phenyl -1,2- dihydrobenzo [4,5] imidazo [1,2-a] pyrazine -3(4H)The synthesis of -one, is as follows:
In the micro-wave oven reaction tube of 10 milliliters of sizes, first by boc-protected aniline compound(0.5 mM)And benzaldehyde (0.5 mM)It is dissolved in 1.0 milliliters of methanol, then again by bromoacetic acid(0.5 mM)With cyclohexyl isocyanide compound (0.5 mM)It sequentially adds in the solution, is stirred a whole night under reaction solution room temperature, then use thin-layer chromatography detection reaction, Solution is dried up using nitrogen.Then after the solvent dissolving for using 10% trifluoroacetic acid and dichloroethanes, under the conditions of 60 DEG C of microwave again Secondary response 10 minutes uses dichloromethane after being spin-dried for solution(30 milliliters)Dissolving, saturation sodium bicarbonate solution washing (2 × 15 milliliters), obtained organic phase product is dissolved with 5.0 milliliters of acetonitrile again, adds potassium carbonate(2.5 mM), in microwave It is reacted 10 minutes for 80 DEG C in stove.The solution uses dichloromethane after being spin-dried for(30 milliliters)Then saturated common salt water washing is used in dissolving (2 × 15 milliliters).After organic phase is using magnesium sulfate drying, silicagel column is detached obtained product again, obtains target 2- rings Hexyl -4- phenyl -1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)-one compound, yield 78%.
1H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.1 Hz, 1H), 7.32-7.28 (m, 4H), 7.20 (t, J = 7.6 Hz, 1H), 7.16-7.12 (m, 3H), 6.05 (s, 1H), 4.83 (d, J = 16.9 Hz, 1H), 4.67 (d, J = 16.9 Hz, 1H), 4.53-4.46 (m, 1H), 1.88-1.68 (m, 6H), 1.58-1.33 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 164.2, 145.8, 143.7, 135.2, 133.2, 129.2, 128.8, 126.1, 123.2, 123.1, 119.7, 109.9, 60.9, 53.7, 40.0, 29.7, 29.2, 25.6, 25.5, 25.3. LC/MS calculated for C22H24N3O [M+H]+, 346; found 346。
Embodiment 8
Wherein R1For hydrogen atom, R2For phenyl, R3For heteroaryl, i.e. 4-(3,4- dichlorophenyls)- 2- phenethyl -1,2- dihydrobenzenes And [4,5] imidazo [1,2-a] pyrazine -3(4H)The synthesis of -one, is as follows:
In the micro-wave oven reaction tube of 10 milliliters of sizes, first by boc-protected aniline compound(0.5 mM)With 3,4- bis- Chlorobenzaldehyde(0.5 mM)It is dissolved in 1.0 milliliters of methanol, then again by bromoacetic acid(0.5 mM)It is different with phenethyl Cyanogen compound(0.5 mM)It sequentially adds in the solution, is stirred a whole night under reaction solution room temperature, then use thin-layer chromatography Detection reaction, solution are dried up using nitrogen.Then after using the dissolving of the solvent of 10% trifluoroacetic acid and dichloroethanes, in microwave 60 It is reacted again under the conditions of DEG C 10 minutes, dichloromethane is used after solution is spin-dried for(30 milliliters)Dissolving, the sodium bicarbonate of saturation are molten Liquid washs (2 × 15 milliliters), and obtained organic phase product is dissolved with 5.0 milliliters of acetonitrile again, adds potassium carbonate(2.5 mmoles You), reacted 10 minutes for 80 DEG C in micro-wave oven.The solution uses dichloromethane after being spin-dried for(30 milliliters)Dissolving, then with saturation Brine It (2 × 15 milliliters).After organic phase is using magnesium sulfate drying, silicagel column is detached obtained product again, is obtained To target 4-(3,4- dichlorophenyls)- 2- phenethyl -1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)-one Close object, yield 71%.
1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 8.1 Hz, 1H), 7.38 (d, J = 8.4 Hz, 1H), 7.31 (t, J = 7.5 Hz, 1H), 7.22- 7.17 (m, 5H), 7.11- 7.01 (m, 3H), 6.89- 6.84 (m, 1H), 5.93 (s, 1H), 4.56 (q, J = 17.1 Hz, 2H), 4.09 (dt, J = 13.6, 6.8 Hz, 1H), 3.55 (dq, J = 20.7, 6.9 Hz, 1H), 2.99 (dt, J = 14.2, 7.2 Hz, 1H), 2.93 -2.84 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 163.40, 144.6, 143.6, 137.5, 135.2, 133.6, 133.4, 132.7, 131.1, 128.7, 128.7, 128.2, 126.9, 125.4, 123.6, 123.4, 119.9, 109.8, 59.7, 49.7, 46.3, 33.1. LC/MS calculated for C24H20Cl2N3O [M+H]+, 436; found 436。
1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 according to the present invention(4H)The key of -one derivative Step is:It is reacted using multicomponent Ugi, Ugi products is obtained under normal temperature condition, which uses under conditions of unpurified 10% trifluoroacetic acid and dichloroethanes dissolving, react 10 minutes under the conditions of 60 DEG C of microwave.Through being spin-dried for after washing operation, then Secondary to be dissolved in acetonitrile solution, using the alkaline condition of potassium carbonate, microwave-assisted reaction is reacted 10 minutes at 80 DEG C, is obtained Target product.1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 according to the present invention(4H)-one derivative is being made Application in standby antitumor drug.

Claims (7)

1. a kind of 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)-one derivative, it is characterised in that:Derivative General structure it is as follows:
2. 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 according to claim 1(4H)-one derivative, It is characterized in that:The R1For hydrogen atom, methyl and halogen.
3. 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 according to claim 1(4H)-one derivative, It is characterized in that:The R2For carbon number be 1-6 alkyl, phenyl substituent.
4. 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 according to claim 1(4H)-one derivative, It is characterized in that:The R3Alkyl, aryl and the heteroaryl for being 1-6 for carbon number.
5. 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 according to claim 1(4H)-one derivative Synthetic method, it is characterised in that:It is reacted using multicomponent Ugi, obtains Ugi products under normal temperature condition, the compound is unpurified Under conditions of, it is dissolved using the solution of 10% trifluoroacetic acid and dichloroethanes, is reacted 10 minutes for 60 DEG C, passed through by microwave radiation technology After being spin-dried for washing operation, using the alkaline condition of potassium carbonate, in acetonitrile solution, microwave-assisted reaction reacts 10 at 80 DEG C Minute, step column chromatography purification, so that it may which, to obtain target product, this reaction process is short, and post-reaction treatment is simple.
6. 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 according to claim 1(4H)-one derivative, It is characterized in that:Synthetic route is as follows:
7. 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3 according to claim 1(4H)-one derivative can Using in the preparation of antitumor drugs.
CN201711440250.7A 2017-12-27 2017-12-27 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)The synthesis of -one derivative Pending CN108314687A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711440250.7A CN108314687A (en) 2017-12-27 2017-12-27 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)The synthesis of -one derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711440250.7A CN108314687A (en) 2017-12-27 2017-12-27 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)The synthesis of -one derivative

Publications (1)

Publication Number Publication Date
CN108314687A true CN108314687A (en) 2018-07-24

Family

ID=62893600

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711440250.7A Pending CN108314687A (en) 2017-12-27 2017-12-27 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)The synthesis of -one derivative

Country Status (1)

Country Link
CN (1) CN108314687A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017068089A2 (en) * 2015-10-23 2017-04-27 Vifor (International) Ag Novel ferroportin inhibitors
CN107353287A (en) * 2017-05-26 2017-11-17 重庆文理学院 A kind of quinoxaline and the preparation of heterocyclic fourth ketone compounds and its application in antitumor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017068089A2 (en) * 2015-10-23 2017-04-27 Vifor (International) Ag Novel ferroportin inhibitors
CN107353287A (en) * 2017-05-26 2017-11-17 重庆文理学院 A kind of quinoxaline and the preparation of heterocyclic fourth ketone compounds and its application in antitumor

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CANKAROVA, NADEZDA等: "Polymer-Supported Stereoselective Synthesis of Benzimidazolinopiperazinones", 《JOURNAL OF ORGANIC CHEMISTRY》 *
CAS RN: "《CAS RN 180635-00-1》", 11 September 1996 *
EL KAIM, LAURENT等: "Multicomponent Synthesis of Fused Benzimidazolopiperazines", 《JOURNAL OF ORGANIC CHEMISTRY》 *
XU, ZHIGANG等: "Expeditious routes to polycyclic molecular frameworks via one-pot, two-step Ugi ring-closing sequences", 《SYNLETT》 *

Similar Documents

Publication Publication Date Title
CN104610250B (en) 1,2,3-thiadiazole-5-formamidine compound containing three N-heterocycles and synthesis
Goeminne et al. Richter cyclization and co-cyclization reactions of triazene-masked diazonium ions
CN104610166B (en) Pyrimidine benzyl hydroxamic acid histone deacetylases inhibitor and preparation method and application
CN104529896B (en) Synthetic method of diaryl substituted isoquinoline compound
Dunwell et al. Synthesis and antiinflammatory activity of some 2-heteroaryl-. alpha.-methyl-5-benzoxazoleacetic acids
CN104529895B (en) Synthetic method of replacing nitrogen-containing heterocyclic compound
CN107286131A (en) A kind of Kinase Selectivity inhibitor
Stevens et al. General methods of alkaloid synthesis. XI. Total synthesis of the sceletium alkaloid A-4 and an improved synthesis of (+-)-mesembrine
CN105524013B (en) 4,5- bis- substitutes the preparation method of -2- substituted-amino thiazolium compounds
CN104844590B (en) A kind of N methyl Ciprofloxacin (rhodanine beta-unsaturated ketone) amide derivatives and its preparation method and application
CN105906622B (en) A kind of preparation method for being used to treat the Pa Boxini of breast cancer
CN108373468A (en) A kind of preparation method of N-2- pyridines -5- pyrimetamines
CN108314687A (en) 1,2- dihydrobenzos [4,5] imidazo [1,2-a] pyrazine -3(4H)The synthesis of -one derivative
CN106946880A (en) A kind of method for preparing Rui Boxini intermediates
CN107176925A (en) A kind of synthetic method of the cyclohexadione compounds of polysubstituted imidazoline 2,4
CN104557701B (en) A kind of preparation method of isoquinilone derivatives
Torje et al. Phenothiazinecarboxaldehyde-hydrazone derivatives synthesis, characterization and electronic properties
Rashid et al. Bargellini condensation of ninhydrin as a ketone and substituted anilines as nucleophiles
El-Sherief et al. Novel method for the synthesis of s-triazolo [3, 4-b][1, 3, 4] thiadiazines
CN105968109B (en) A kind of method for preparing Pa Boxini intermediates
CN107176956A (en) A kind of IDO inhibitor compound, Pharmaceutical composition, purposes
CN107353287B (en) A kind of quinoxaline and heterocyclic fourth ketone compounds and its application in antitumor
CN113527236A (en) Method for preparing amiodarone hydrochloride
Klemm et al. Chemistry of thienopyridines. XXIX. The reissert‐henze reaction as a route to simple c‐substituents alpha to the heteronitrogen atom
CN109206430B (en) Thiourea catalytic synthesis of nitrogen-containing ternary polycyclic chiral compound and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180724

RJ01 Rejection of invention patent application after publication